Abnormal diastolic currents in ventricular myocytes from spontaneous hypertensive heart failure rats

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 291, Issue 5, 2006, Pages

  Sridhar, Arun ^a,b   Dech, Spencer J ^a,b,c   Lacombe, Veronique A ^a,b   Elton, Terry S ^a,b   McCune, Sylvia A ^b,d,e   Altschuld, Ruth A ^a,b   Carnes, Cynthia A ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

^d Myogen Inc   (United States)

^e UNIVERSITY OF COLORADO   (United States)

Author keywords

Abnormal automaticity; Aging; Inward rectifier potassium current; Pacemaker current

Indexed keywords

ZATEBRADINE;

ACTION POTENTIAL; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; HEART AUTOMATICITY; HEART FAILURE; HEART MUSCLE CELL; HEART VENTRICLE; HYPERTENSION; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; RAT;

ACTION POTENTIALS; AGING; ANIMALS; BENZAZEPINES; BODY WEIGHT; CARDIOTONIC AGENTS; DIASTOLE; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE, CONGESTIVE; HEART VENTRICLES; HYPERTENSION; MALE; MYOCYTES, CARDIAC; ORGAN SIZE; PATCH-CLAMP TECHNIQUES; RATS; RATS, INBRED SHR; RATS, INBRED WF; RATS, WISTAR;

EID: 33751163745     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01146.2005     Document Type: Article

References (40)

1. Bikkina M, Larson MG, and Levy D. Asymptomatic ventricular arrhythmias and mortality risk in subjects with left ventricular hypertrophy. J Am Coll Cardiol 22: 1111-1116, 1993.
2. + current. Int J Androl 25: 210-214, 2002.
3. Carnes CA, Muir WW III, and Van Wagoner DR. Effect of intravenous anesthetics on inward rectifier potassium current in rat and human ventricular myocytes. Anesthesiology 87: 327-334, 1997.
4. f, in ventricular myocytes isolated from hypertensive rats. J Physiol 481: 585-591, 1994.
5. f in ventricular myocytes from normotensive and hypertensive rats during aging. Circulation 94: 1674-1681, 1996.
6. f, in ventricular myocytes from human failing heart. Circulation 95: 568-571, 1997.
7. f in human ventricular myocytes are modulated by cardiac disease. J Mol Cell Cardiol 33: 441-448, 2001.
8. Dumitrescu C, Narayan P, Efimov IR, Cheng Y, Radin MJ, McCune SA, and Altschuld RA. Mechanical alternans and restitution in failing SHHF rat left ventricles. Am J Physiol Heart Circ Physiol 282: H1320-H1326, 2002.
9. Fariello R, Crippa M, Damiani G, Notaristefano I, Costa R, Boni E, Corda L, Chiari E, and Zaninelli A. Ventricular arrhythmias in normotensive subjects and in mild hypertensive patients. Angiology 49: 99-103, 1998.
10. Fleg JL and Kennedy HL. Long-term prognostic significance of ambulatory electrocardiographic findings in apparently healthy subjects greater than or equal to 60 years of age. Am J Cardiol 70: 748-751, 1992.
11. Francis GS. Development of arrhythmias in the patient with congestive heart failure: pathophysiology, prevalence and prognosis. Am J Cardiol 57: 3B-7B, 1986.
12. Gill CH, Randall A, Bates SA, Hill K, Owen D, Larkman PM, Cairns W, Yusaf SP, Murdock PR, Strijbos PJ, Powell AJ, Benham CD, and Davies CH. Characterization of the human HCN1 channel and its inhibition by capsazepine. Br J Pharmacol 143: 411-421, 2004.
13. Haigney MC, Wei S, Kaab S, Griffiths E, Berger R, Tunin R, Kass D, Fisher WG, Silver B, and Silverman H. Loss of cardiac magnesium in experimental heart failure prolongs and destabilizes repolarization in dogs. J Am Coll Cardiol 31: 701-706, 1998.
14. Hamlin RL. Measurements of left and right ventricular pressures and their derivatives by transcutaneous puncture in rats. Am J Vet Res 53: 34-35, 1992.
15. Heyen JR, Blasi ER, Nikula K, Rocha R, Daust HA, Frierdich G, Van Vleet JF, De Ciechi P, McMahon EG, and Rudolph AE. Structural, functional, and molecular characterization of the SHHF model of heart failure. Am J Physiol Heart Circ Physiol 283: H1775-H1784, 2002.
16. Kaab S, Nuss HB, Chiamvimonvat N, O'Rourke B, Pak PH, Kass DA, Marban E, and Tomaselli GF. Ionic mechanism of action potential prolongation in ventricular myocytes from dogs with pacing-induced heart failure. Circ Res 78: 262-273, 1996.
17. Kambara A, Holycross BJ, Wung P, Schanbacher B, Ghosh S, McCune SA, Bauer JA, and Kwiatkowski P. Combined effects of low-dose oral spironolactone and captopril therapy in a rat model of spontaneous hypertension and heart failure. J Cardiovasc Pharmacol 41: 830-837, 2003.
18. Komsuoglu B, Duman E, Komsuoglu SS, and Gorcin B. Prevalence of ventricular premature complexes in healthy and untreated hypertensive elderly people. Angiology 44: 447-453, 1993.
19. Kontoleon PE, Anastasiou-Nana MI, Papapetrou PD, Alexopoulos G, Ktenas V, Rapti AC, Tsagalou EP, and Nanas JN. Hormonal profile in patients with congestive heart failure. Int J Cardiol 87: 179 -183, 2003.
20. Leblanc N, Chartier D, Gosselin H, and Rouleau JL. Age and gender differences in excitation-contraction coupling of the rat ventricle. J Physiol 511: 533-548, 1998.
21. Levy D, Anderson KM, Plehn J, Savage DD, Christiansen JC, and Castelli WP. Echocardiographically determined left ventricular structural and functional correlates of complex or frequent ventricular arrhythmias on one-h ambulatory electrocardiographic monitoring. Am J Cardiol 59: 836-840, 1987.
22. Levy D, Larson MG, Vasan RS, Kannel WB, and Ho KK. The progression from hypertension to congestive heart failure. JAMA 275: 1557-1562, 1996.
23. Lopatin AN, Makhina EN, and Nichols CG. The mechanism of inward rectification of potassium channels: "long-pore plugging" by cytoplasmic polyamines. J Gen Physiol 106: 923-955, 1995.
24. Lopatin AN, Shantz LM, Mackintosh CA, Nichols CG, and Pegg AE. Modulation of potassium channels in the hearts of transgenic and mutant mice with altered polyamine biosynthesis. J Mol Cell Cardiol 32: 2007-2024, 2000.
25. McCune SA, Baker PB, and Stills HF. SHHF/Mcc-cp rat: model of obesity, non-insulin-dependent diabetes and congestive heart failure. ILAR News 32: 23-37, 1990.
26. cp rat model: a genetic model of congestive heart failure. In: Mechanisms of Heart Failure, edited by Singal PK, Dixon IMC, Beamish RE, and Dhalla NS. Norwell, MA: Kluwer Acad., 1995, p. 91-106.
27. Nichols CG, Makhina EN, Pearson WL, Sha Q, and Lopatin AN. Inward rectification and implications for cardiac excitability. Circ Res 78: 1-7, 1996.
28. Onodera T, Tamura T, Said S, McCune SA, and Gerdes AM. Mal-adaptive remodeling of cardiac myocyte shape begins long before failure in hypertension. Hypertension 32: 753-757, 1998.
29. Ottenweller JE, Tapp WN, Creighton D, and Natelson BH. Aging, stress, and chronic disease interact to suppress plasma testosterone in Syrian hamsters. J Gerontol 43: M175-M180, 1988.
30. Pogwizd SM, Schlotthauer K, Li L, Yuan W, and Bers DM. Arrhythmogenesis and contractile dysfunction in heart failure: roles of sodium-calcium exchange, inward rectifier potassium current, and residual beta-adrenergic responsiveness. Circ Res 88: 1159-1167, 2001.
31. Reffelmann T and Kloner RA. Transthoracic echocardiography in rats. Evalution of commonly used indices of left ventricular dimensions, contractile performance, and hypertrophy in a genetic model of hypertrophic heart failure (SHHF-Mcc-facp-rats) in comparison with Wistar rats during aging. Basic Res Cardiol 98: 275-284, 2003.
32. Rose J, Armoundas AA, Tian Y, Disilvestre D, Burysek M, Halperin V, O'Rourke B, Kass DA, Marban E, and Tomaselli GF. Molecular correlates of altered expression of potassium currents in failing rabbit myocardium. Am J Physiol Heart Circ Physiol 288: H2077-H2087, 2005.
33. Ruskoaho H and Raunio H. Altered cardiac polyamine biosynthesis in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 253: H262-H269, 1987.
34. Saadeh AM and Jones JV. Predictors of sudden cardiac death in never previously treated patients with essential hypertension: long-term follow-up. J Hum Hypertens 15: 677-680, 2001.
35. Siegel D, Cheitlin MD, Black DM, Seeley D, Hearst N, and Hulley SB. Risk of ventricular arrhythmias in hypertensive men with left ventricular hypertrophy. Am J Cardiol 65: 742-747, 1990.
36. Tamura T, Onodera T, Said S, and Gerdes AM. Correlation of myocyte lengthening to chamber dilation in the spontaneously hypertensive heart failure (SHHF) rat. J Mol Cell Cardiol 30: 2175-2181, 1998.
37. Tamura T, Said S, Harris J, Lu W, and Gerdes AM. Reverse remodeling of cardiac myocyte hypertrophy in hypertension and failure by targeting of the renin-angiotensin system. Circulation 102: 253-259, 2000.
38. Thomas TA, Kuzman JA, Anderson BE, Andersen SM, Schlenker EH, Holder MS, and Gerdes AM. Thyroid hormones induce unique and potentially beneficial changes in cardiac myocyte shape in hypertensive rats near heart failure. Am J Physiol Heart Circ Physiol 288: H2118-H2122, 2005.
39. f) by cilobradine and zatebradine. Eur J Pharmacol 478: 161-171, 2003.
40. Walker KE, Lakatta EG, and Houser SR. Age associated changes in membrane currents in rat ventricular myocytes. Cardiovasc Res 27: 1968-1977, 1993.